Avio S.p.A. (BIT:AVIO)

Market Cap	875.89M
Revenue (ttm)	480.42M
Net Income (ttm)	6.09M
Shares Out	26.07M
EPS (ttm)	0.23
PE Ratio	146.09
Forward PE	72.08
Dividend	0.15 (0.44%)
Ex-Dividend Date	May 5, 2025

Volume	124,535
Average Volume	320,669
Open	33.85
Previous Close	33.60
Day's Range	33.65 - 34.75
52-Week Range	11.40 - 35.65
Beta	0.58
RSI	74.50
Earnings Date	Sep 11, 2025

About Ligand Pharmaceuticals

Avio S.p.A., through its subsidiaries, designs, develops, produces, and integrates space launchers in Italy and internationally. The company involved in the design, development, and production of solid and liquid propulsion systems for launchers; design, development, and production of solid propulsion systems for tactical missiles; development, integration, and supply of complete light space launchers; research and development of new environmentally friendly propulsion systems and attitude control engines for satellites; liquid propulsion syste...

• Industry: Aerospace & Defense
• Sector: Industrials
• Founded: 1984
• Employees: 1,355
• Stock Exchange: Borsa Italiana
• Ticker Symbol: AVIO

Financial Performance

In 2024, Avio S.p.A.'s revenue was 480.42 million, an increase of 39.78% compared to the previous year's 343.70 million. Earnings were 6.09 million, a decrease of -6.17%.